The Union Health Minister Mansukh Mandaviya said that the World Health Organization (WHO) is set to meet on October 26 to consider much-coveted emergency use approval to Covaxin, India's indigenously made vaccine against COVID-19.
The universal health body's technical advisory group is meeting to consider the emergency use listing (EUL) of the vaccine, the minister said. “World Health Organization has a system in which there is a technical committee which has approved it (Covaxin) while the other committee is meeting today. The approval for Covaxin will be given on the basis of today's meeting,” Mandaviya shared details before media.
Notably, Bharat Biotech, the Hyderabad-based pharmaceutical company which developed Covaxin, has now been waiting for months for the specialised United Nations (UN) agency to provide a formal nod to its Covid-19 vaccine.
The WHO approval for Covaxin’s emergency use authorisation is vital for its widespread acceptability as a safe and effective vaccine. currently, India is using Covaxin in its nationwide inoculation drive against Covid-19 as one of the six vaccines approved by the Drugs Controller General of India, including the Oxford-AstraZeneca’s Covishield and the Russian-made Sputnik V.